Not Signed In -
Doxepin |
Adapin; Sinequan |
Doxepin Systematic (IUPAC) name 11-(3-(Dimethylamino) propylidene)-6H-dibenz(b,e)oxepine Identifiers CAS number 1668-19-5 ATC code N06AA12 PubChem 3158 DrugBank APRD00398 Chemical data Formula C19H21NO Mol. weight 279.376 g/mol Pharmacokinetic data Bioavailability Absolute = 25%. When main metabolite desmethyldoxepin is included: 31% Metabolism Hepatic Half life Doxepin 17h, main metabolite Desmethyldoxepin 51h Excretion Renal Therapeutic considerations ...
Wikipedia - [full article]
Doxepin News Headlines
- Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results In Its Third Phase 3 Clinical Trial In Insomnia
MedicalNewsToday - Tue, 21 Nov 2006 08:00 EST
- Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results In A Phase 3 Transient Insomnia Clinical Trial
MedicalNewsToday - Tue, 24 Oct 2006 07:00 EST
- Somaxon Pharmaceuticals Provides Update On Preclinical And Clinical Programs For SILENOR(TM)
MedicalNewsToday - Tue, 12 Sep 2006 07:00 EST
- Somaxon Pharmaceuticals Provides Update On SILENOR(TM) Development Program For The Treatment Of Insomnia
MedicalNewsToday - Thu, 20 Jul 2006 06:00 EST
- Somaxon Pharmaceuticals Announces Presentation Of Phase 2 SILENOR(TM) Data At The Associated Professional Sleep Societies Annual Meeting
MedicalNewsToday - Wed, 21 Jun 2006 06:00 EST
- Phase 3 Data Show New Insomnia Drug, Silenor™, Effective Without Side Effects
MedicalNewsToday - Wed, 12 Apr 2006 06:00 EST
email this page
print this page
bookmark this page
feedback on this page
